6
Stories per week
2
Expert Writers
20,000
Subscribers
Weekly
Frequency

Professional Audience
Wide scope of biotech and pharma industry executives, as well as those from contract research organizations who need to know first about developments in drug delivery.

Content Focus
Innovative drug delivery technology such as gene therapy, RNAi, novel devices and the partnering and acquisition activity that influences their investment, development, adaptation and use.

Reader Demographics

Pharmaceutical - 33%
Biotech - 18%
Other - 16%
Consultant - 8%
Contract Research Organization - 6%
Medical - 4%
Chemicals - 4%
Financial - 2%
Advertising/Marketing/Public Relations - 2%
Medical Devices & Diagnostics - 2%
Contract Manufacturing Organization - 2%
Government - 1%
Clinical Trials - 1%
Life Sciences IT - 1%

Manager - 30%
Staff - 23%
C-Level - 20%
Director - 17%
Pres/VP/SVP/EVP - 10%

Marketing & Brand Management - 14%
Executive Management - 12%
Other - 12%
Laboratory/R&D - 12%
Operations - 9%
Pharmacovigilence/Regulatory - 8%
Consultant - 6%
Clinical Operations - 6%
Business Development - 5%
Finance - 3%
Project Management - 3%
Clinical/Preclinical Research - 2%
Medical Affairs/Writing - 2%
Facility Design/Production - 2%
Packaging/Logistics/Distribution - 2%
Purchasing/Procurement/Acquisitions - 1%
Engineering - 1%

North America - 64%
Asia Pacific - 21%
Europe - 14%
Other - 1%